Cleveland Clinic Heart, Vascular and Thoracic Institute
Check The Cleveland Clinic Tall Rounds® series:
https://www.vumedi.com/channel/cleveland-clinic/tab/aorta-disease/video/cleveland-clinic-tall-roundsr/
https://www.vumedi.com/channel/cleveland-clinic/tab/aorta-disease/video/cleveland-clinic-tall-roundsr/
- Aorta Disease
- Congenital Heart
- Coronary Artery Disease
- Electrophysiology
- Heart Failure
- Preventive Cardiology
- Valve Disease
- Vascular and Arterial Disease
- Thoracic: Lungs and Esophageal
- Events
Playback speed
10 seconds
ESC 2018 Highlights of Late Breaking Trials
0 views
February 5, 2019
Dr. Steven Nissen, Chairman of Cardiovascular Medicine at Cleveland Clinic reviews the results from five ...
read more ↘ clinical trials presented at the European Society of Cardiology Conference which may impact clinical practice: 1) The ATTR-ACT Study (the use of the drug tafamidis in patients who have transthyretin amyloid cardiomyopathy); 2) the ARRIVE and ASCEND studies (the benefits and risks of aspirin use in primary prevention); 3) the AIMS study (impact of irbesartan on rate of aortic dilation in patients with Marfan Syndrome); and last MITRA-FR, (outcomes of MitraClip in patients with functional MR).
↖ read less
read more ↘ clinical trials presented at the European Society of Cardiology Conference which may impact clinical practice: 1) The ATTR-ACT Study (the use of the drug tafamidis in patients who have transthyretin amyloid cardiomyopathy); 2) the ARRIVE and ASCEND studies (the benefits and risks of aspirin use in primary prevention); 3) the AIMS study (impact of irbesartan on rate of aortic dilation in patients with Marfan Syndrome); and last MITRA-FR, (outcomes of MitraClip in patients with functional MR).
↖ read less
Comments 0
Login to view comments.
Click here to Login
Heart Failure